Literature DB >> 22791753

The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis.

Lynne Robinson1, Ioannis D Gallos, Sarah J Conner, Madhurima Rajkhowa, David Miller, Sheena Lewis, Jackson Kirkman-Brown, Arri Coomarasamy.   

Abstract

STUDY QUESTION: Is there an association between high levels of sperm DNA damage and miscarriage? SUMMARY ANSWER: Miscarriage rates are positively correlated with sperm DNA damage levels. WHAT IS KNOWN ALREADY: Most ejaculates contain a subpopulation of sperm with DNA damage, also referred to as DNA fragmentation, in the form of double or single-strand breaks which have been induced in the DNA prior to or following ejaculation. This DNA damage may be particularly elevated in some subfertile men, hence several studies have examined the link between sperm DNA damage levels and conception and miscarriage rates. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis of studies which examined the effect of sperm DNA damage on miscarriage rates was performed. Searches were conducted on MEDLINE, EMBASE and the Cochrane Library without any language restrictions from database inception to January 2012. PARTICIPANTS/MATERIALS, SETTING,
METHODS: We used the terms 'DNA damage' or 'DNA fragmentation' combined with 'miscarriage', 'abortion' or 'pregnancy' to generate a set of relevant citations. Data extraction was performed by two reviewers. Study quality was assessed using the Newcastle-Ottawa Scale. Meta-analysis of relative risks of miscarriage was performed with a random effects model. Subgroup analyses were performed by the type of DNA damage test, whether the sperm examined were prepared or from raw semen and for pregnancies resulting from IVF or ICSI treatment. MAIN RESULTS AND THE ROLE OF CHANCE: We identified 16 cohort studies (2969 couples), 14 of which were prospective. Eight studies used acridine orange-based assays, six the TUNEL assay and two the COMET assay. Meta-analysis showed a significant increase in miscarriage in patients with high DNA damage compared with those with low DNA damage [risk ratio (RR) = 2.16 (1.54, 3.03), P < 0.00001)]. A subgroup analysis showed that the miscarriage association is strongest for the TUNEL assay (RR = 3.94 (2.45, 6.32), P < 0.00001). LIMITATIONS, REASONS FOR CAUTION: There is some variation in study characteristics, including the use of different assays and different thresholds for DNA damage and the definition of pregnancy loss. WIDER IMPLICATIONS OF THE
FINDINGS: The use of methods which select sperm without DNA damage for use in assisted conception treatment may reduce the risk of miscarriage. This finding indicates that assays detecting DNA damage could be considered in those suffering from recurrent pregnancy loss. Further research is necessary to study the mechanisms of DNA damage and the potential therapeutic effects of antioxidant therapy. STUDY FUNDING/COMPETING INTEREST(S): None.

Entities:  

Mesh:

Year:  2012        PMID: 22791753     DOI: 10.1093/humrep/des261

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  140 in total

1.  Paternal and maternal preconception urinary phthalate metabolite concentrations and child behavior.

Authors:  Carmen Messerlian; David Bellinger; Lidia Mínguez-Alarcón; Megan E Romano; Jennifer B Ford; Paige L Williams; Antonia M Calafat; Russ Hauser; Joseph M Braun
Journal:  Environ Res       Date:  2017-07-21       Impact factor: 6.498

2.  Which isolated sperm abnormality is most related to sperm DNA damage in men presenting for infertility evaluation.

Authors:  Stephanie Belloc; Moncef Benkhalifa; Martine Cohen-Bacrie; Alain Dalleac; Hikmat Chahine; Edouard Amar; Armand Zini
Journal:  J Assist Reprod Genet       Date:  2014-02-25       Impact factor: 3.412

3.  Removal of DNA-fragmented spermatozoa using flow cytometry and sorting does not improve the outcome of intracytoplasmic sperm injection.

Authors:  Christian De Geyter; Ursula Gobrecht-Keller; Astrid Ahler; Manuel Fischer
Journal:  J Assist Reprod Genet       Date:  2019-08-28       Impact factor: 3.412

4.  The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS).

Authors:  A E Calogero; A Aversa; S La Vignera; G Corona; A Ferlin
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

Review 5.  Sperm selection using magnetic activated cell sorting (MACS) in assisted reproduction: a systematic review and meta-analysis.

Authors:  Monica Gil; Valerie Sar-Shalom; Yolisid Melendez Sivira; Ramon Carreras; Miguel Angel Checa
Journal:  J Assist Reprod Genet       Date:  2013-03-07       Impact factor: 3.412

6.  Paternal and maternal urinary phthalate metabolite concentrations and birth weight of singletons conceived by subfertile couples.

Authors:  Carmen Messerlian; Joseph M Braun; Lidia Mínguez-Alarcón; Paige L Williams; Jennifer B Ford; Vicente Mustieles; Antonia M Calafat; Irene Souter; Thomas Toth; Russ Hauser
Journal:  Environ Int       Date:  2017-06-27       Impact factor: 9.621

7.  X-y interactions underlie sperm head abnormality in hybrid male house mice.

Authors:  Polly Campbell; Michael W Nachman
Journal:  Genetics       Date:  2014-02-05       Impact factor: 4.562

Review 8.  Increasing associations between defects in phospholipase C zeta and conditions of male infertility: not just ICSI failure?

Authors:  Junaid Kashir
Journal:  J Assist Reprod Genet       Date:  2020-04-14       Impact factor: 3.412

9.  The impact of semen quality, occupational exposure to environmental factors and lifestyle on recurrent pregnancy loss.

Authors:  Wang Ruixue; Zhou Hongli; Zhang Zhihong; Dai Rulin; Geng Dongfeng; Liu Ruizhi
Journal:  J Assist Reprod Genet       Date:  2013-09-18       Impact factor: 3.412

10.  Role of Disulfide Bonds on DNA Packaging Forces in Bull Sperm Chromatin.

Authors:  James M Hutchison; Donald C Rau; Jason E DeRouchey
Journal:  Biophys J       Date:  2017-11-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.